Warning: These 2 Stocks Have Dangerous Levels of Debt

Corporate debt looks dangerously high for Advanz Pharma (TSX:ADVZ) and Just Energy Group (TSX:JE).

Shopping card with boxes labelled REITs, ETFs, Bonds, Stocks

Image source: Getty Images.

Nearly every company uses some leverage to boost performance. Borrowing money to invest in productive assets isn’t necessarily bad. However, if the debt burden grows larger than annual earnings or the book value of the company’s equity, the situation becomes decidedly unsustainable. 

Stocks with an unsustainable amount of debt are probably the riskiest ones on the market. A sudden rise in interest rates or a sudden drop in earnings could push these companies over the edge and destroy shareholder value.

Here are two stocks that seem to be dealing with such a situation:

Just Energy

Providing utility services is usually a stable business, making it easier for companies in this industry to borrow extraordinary amounts. However, Mississauga-based natural gas and electricity provider Just Energy Group (TSX:JE)(NYSE:JE) seems to be overdoing it. 

According to its latest filing, the company’s long-term debt burden is worth $774.9 million. Meanwhile, the company’s total market capitalization is $324 million at the time of writing.

In other words, debt is worth twice the company’s market value. Debt is also four times greater than operating annual earnings. 

There’s no doubt that the company is in a tight spot, but management is stepping in to turn the ship around. “I continue to work with the Board and the Special Committee on a robust strategic review process and getting the best outcome for Just Energy’s investors,” said Founder and Executive Chair Rebecca MacDonald in a statement last year. 

Meanwhile, the stock has lost over half its value in 2019 and has been the target of some notorious short sellers. This isn’t a stock for the faint of heart.

Advanz Pharma

Supplying specialty pharmaceuticals is a complicated and risky business. Adding debt to the mixture is probably worse. Advanz Pharma (TSX:ADVZ) seems to have struggled with debt enough in the past to implement a recapitalization last year and rename the company. 

However, the company still holds $1.34 billion in debt on its books, which is 7.6 greater than its market capitalization. Unsurprisingly, the company has been shedding market value despite the corporate restructuring last year. Over the course of 2019, it lost 86% of its value.  

The company seems to be pinning its hopes of revival on its development pipeline. There are seven medicines on its portfolio for potential future launches.

However, in my experience, getting drugs to market is notoriously difficult, expensive and time-consuming. And time is a luxury Advanz Pharma doesn’t appear to have.

All signs indicate that this is a company in terminal decline.

Bottom line

Corporate debt isn’t inherently bad. In fact, some of the best companies in the world use leverage in clever ways in order to create value for shareholders over the long-term.

However, when the debt burden is multiple times annual cash flow or the market value of the entire company, that’s a gigantic red flag for investors.

While some investors may still consider these stocks as contrarian or speculative bets that can deliver unbelievable returns with any positive catalyst, I, personally, would rather stay away and invest in reliable growth or high-yield dividend stocks.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned. 

More on Investing

grow dividends
Dividend Stocks

These 3 Stocks Could Grow (at Least 5X) in the Next Decade if They Repeat History

Three stocks could soar by least five times more if they repeat history with the return of a bull market.

Read more »

analyze data

Brookfield Stock: Deep Value Hiding in Plain Sight as Shares Sink to 52-Week Lows

Brookfield Corp. (TSX:BN) stock seems like a great buy versus Brookfield Asset Management (TSX:BAM) for TSX value investors.

Read more »

Illustration of bull and bear

3 Stocks to Buy if You Think There’s a Bull Market Coming

Are you anticipating a bull market? Here are three stocks to buy!

Read more »

online shopping
Tech Stocks

Is Shopify Stock a Buy in March?

Shopify stock has had a volatile run, but fundamentals are strong, and valuations are much lower after its 71% decline.

Read more »

data analyze research
Tech Stocks

2 Top Stocks to Buy in March 2023

Given their solid financials and high-growth prospects, these two stocks are excellent buys right now.

Read more »

work from home
Dividend Stocks

3 Stocks to Hold for the Next 20 Years

Are you looking for some stocks to hold for 20 years or more? Here are three great options to consider…

Read more »

little girl in pilot costume playing and dreaming of flying over the sky
Dividend Stocks

3 Stocks You’ll Probably Be Able to Pass On to Your Grandkids

Three stocks are ideal holdings for generational wealth builders who will eventually pass these assets to the next generation or…

Read more »

Dividend Stocks

SmartCentres: Is Your Dividend at This REIT Safe?

The interest rate hike has pulled down property prices. Should you be worried about your monthly passive income from this…

Read more »